elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35826528-4B4FA92A-DF41-4238-894E-F3D356E4A0EF
Q35826528-4B4FA92A-DF41-4238-894E-F3D356E4A0EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35826528-4B4FA92A-DF41-4238-894E-F3D356E4A0EF
A semimechanistic and mechanistic population PK-PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis.
P2860
Q35826528-4B4FA92A-DF41-4238-894E-F3D356E4A0EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35826528-4B4FA92A-DF41-4238-894E-F3D356E4A0EF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1cb5ff745bce95200251512a7ca67b475a26b7c7
P2860
Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women.